Quantisnow Logo
Dashboard

Nature's Sunshine Sets Third Quarter 2024 Conference Call for Thursday, November 7, 2024, at 5:00 p.m. ET

$NATR
Biotechnology: Pharmaceutical Preparations
Health Care
Get the next $NATR alert in real time by email

LEHI, Utah, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, will conduct a conference call on Thursday, November 7, 2024, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2024. The company will report its financial results in a press release prior to the conference call.

Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period.

Date: Thursday, November 7, 2024

Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)

Toll-free dial-in number: 1-800-717-1738

International dial-in number: 1-646-307-1865

Conference ID: 03533

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

The conference call will be broadcast live and available for replay here and via the Events section of the Nature's Sunshine website here.

A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through Thursday, November 21, 2024.

Toll-free replay number: 1-844-512-2921

International replay number: 1-412-317-6671

Replay ID: 1103533

About Nature's Sunshine

Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the company can be obtained at its website, www.naturessunshine.com.

Investor Relations:

Gateway Group, Inc.

Cody Slach

1-949-574-3860

NATR@gateway-grp.com



Primary Logo

Get the next $NATR alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Q&A

New

  • When will Nature's Sunshine Products hold its conference call regarding its third quarter financial results?

    Nature's Sunshine Products is scheduled to conduct a conference call to discuss its third quarter financial results on Thursday, November 7, 2024, at 5:00 p.m. Eastern time.

  • Who will host the conference call for Nature's Sunshine Products?

    CEO Terrence Moorehead and CFO Shane Jones will host the conference call.

  • When will the replay of the conference call be available and for how long?

    The conference call will be available for replay after 8:00 p.m. Eastern time on the same day until Thursday, November 21, 2024.

  • What are the dial-in numbers for the Nature's Sunshine conference call?

    Participants can dial 1-800-717-1738 for a toll-free call in the United States, or 1-646-307-1865 for international calls.

  • What are some key aspects of Nature's Sunshine Products as a company?

    Nature's Sunshine Products markets and distributes nutritional and personal care products in over 40 countries and manufactures many products in their own facilities to ensure high quality.

Recent Analyst Ratings for
$NATR

DatePrice TargetRatingAnalyst
9/13/2024$18.00Buy
Canaccord Genuity
3/9/2022$24.00 → $24.50Buy
DA Davidson
11/5/2021$22.00 → $24.00Buy
DA Davidson
10/15/2021$22.00Buy
DA Davidson
More analyst ratings

$NATR
 Press Releases

Fastest customizable press release news feed in the world

See more

  • Nature's Sunshine Reports Fourth Quarter and Full Year 2024 Financial Results

    LEHI, Utah, March 11, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 8.5% to $118.2 million compared to $108.9 million (up 10.0% in constant currency).GAAP net loss attributable to common shareholders of $0.3 million, or $(0.02) per diluted share, compared to net income of $9.0 million, or $0.46 per diluted share.Adjusted EBITDA up 6% to $10.3 million com

    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

  • Nature's Sunshine Launches First Integrated Brand Platform

    LEHI, Utah, March 03, 2025 (GLOBE NEWSWIRE) -- Leading natural health and wellness company Nature's Sunshine announces today the launch of its new brand platform, "Be More Earth." In the brand's first integrated platform created in partnership with media and creative agency Crispin, the spotlight is on Nature's Sunshine's storied history of harnessing nature's healing powers and sharing it with consumers. The entire brand platform and visual design are inspired by the Earth – its uniqueness, natural beauty and restorative power – while honoring over 50 years of sourcing the finest ingredients it has to offer. "We believe that the Earth has the healing power that all customers deserve. Our

    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

  • Nature's Sunshine Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, March 11, 2025, at 5:00 p.m. ET

    LEHI, Utah, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 11, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 11, 2025Time: 5:00 p.m. Eastern time (3:00 p.m.

    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

$NATR
 Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$NATR
 Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$NATR
 SEC Filings

See more

$NATR
 Leadership Updates

Live Leadership Updates

See more

  • Nature's Sunshine Appoints Katie A. May to Board of Directors

    LEHI, Utah, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Ms. Katie A. May to its board of directors effective January 30, 2025. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. "Katie brings significant experience scaling and leading high-growth B2C, ecommerce and logistics companies," said Richard D. Moss, Chairman of the Board of Nature's Sunshine. "Her deep understanding of the full ecommerce lifecycle will strengthen and enhance our digital capabilities and drive s

    $NATR
    $PBI
    $STMP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Office Equipment/Supplies/Services
    Miscellaneous

  • Nature's Sunshine Appoints Steven Fasching to Board of Directors

    LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors. "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Ste

    $DECK
    $NATR
    Shoe Manufacturing
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

  • Nature's Sunshine Names Kevin Fuller Global Chief Marketing Officer

    LEHI, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Kevin Fuller as Global Chief Marketing Officer, effective September 23, 2024. Fuller, a seasoned marketing executive with over two decades of experience in high-performance organizations, brings in-depth global marketing experience to Nature's Sunshine. His deep understanding of the dietary supplement industry combined with his experience launching new products, building powerful brands, and driving customer growth strategies make Fuller an ideal fit for Nature's Sunshine. "We are ver

    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

$NATR
 Financials

Live finance-specific insights

See more

  • Nature's Sunshine Reports Fourth Quarter and Full Year 2024 Financial Results

    LEHI, Utah, March 11, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 8.5% to $118.2 million compared to $108.9 million (up 10.0% in constant currency).GAAP net loss attributable to common shareholders of $0.3 million, or $(0.02) per diluted share, compared to net income of $9.0 million, or $0.46 per diluted share.Adjusted EBITDA up 6% to $10.3 million com

    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

  • Nature's Sunshine Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, March 11, 2025, at 5:00 p.m. ET

    LEHI, Utah, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 11, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 11, 2025Time: 5:00 p.m. Eastern time (3:00 p.m.

    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

  • Nature's Sunshine Reports Third Quarter 2024 Results

    LEHI, Utah, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 3% to $114.6 million compared to $111.2 million (up 4% in constant currency).GAAP net income attributable to common shareholders was $4.3 million, or $0.23 per diluted common share, compared to $2.8 million, or $0.15 per diluted common share.Adjusted EBITDA was up 5% to $10.7 million compared to $10.3 million. Management

    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

$NATR
 Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more